Andrx Pharmaceuticals, Inc.

Other

Andrx Corporation, Inc.

Andrx Labs, LLC

Benq Corporation

Pegatron Corporation

Twi Biotechnology, Inc.

Inventec Corp.

Inventec (Pudong) Technology Corporation

Trend Micro Inc.

Asustek Computer Inc.

Qisda Corporation

Taiwan Colour and Imaging Technology Corporation

Twi Pharmaceuticals, Inc.

Golden Biotechnology Corporation

Chih-Ming Chen

Joseph C Chou

Xiu Xiu Cheng

Steve Jan

Unchalee Kositprapa

Jianbo Xie

David N Wong

Sheng-Yung Liu

Timothy Weng

Der-Yang Lee

Manesh Dixit

Chih-Liang Chiang

Jeng-Hong Chiu

Cheng-Shi Jiang

Boyong Li

Mannching Sherry Ku

Wu-Che Wen

Wei-Shu Lu

Tzu-Ming Yang

I-Yin Lin, Iii

Xiu-Xiu Cheng

Yu-Han Kao

Shih-Fen Liao

Yen-Chih Kuo

Chian-Ting Chen

Yu-Yin Chen

Fan-Lun Liu

Charles S Chiao

Joseph C H Chou

Guang-Wei Lu

Chou-Hsiung Chen

Ling-Ying Liaw

Janice Louise Cacace

Avinash Nangia

Jose I Suarez

Chih-Kuang Chen

Chao-Kai Huang

Elliot F Hahn

Dacheng Tian

Yi-Fen Chen

Chun-Yi Chang

Kai Yu

Ming-Te Hung

Mongkol Sriwongjanya

Hung-Chung Ku

Yu-Hao Chiu

Hung-Cheng Lee

Huai-Wen Hsu

Unchalee Lodin

Pei-Chun Kuo

Nilobon Podhipleux

Danchen Gao

Jane Chen

Jane Chang Chen

Jainbo Xie

Feng-Hsun Mo

Aurelio Rodriguez

Yng-Shean Guo

Cheng-Yu Ko

Zhang-Zheng Lin

Wen-Hong Lu

Jie-Wen Yang

Chung-Yu Wu

I-Chan Wu

Wen-Tai Liu

Hsiu-Yi Cheng

Jen-Sen Wu

Yu-Shu Zheng

Yen-Chi Kuo

I-Yin Lin

Hao-Yu Cheng

Shouchiung Chen

A wireless transmission system includes a signal-transmitting device and a signal-receiving device. The signal-transmitting device is disposed in a remote-control apparatus for transmitting wireless signals wherein the remote-control apparatus is a mouse. The signal-receiving device is installed on an electronic apparatus to receive the wireless signals and trigger operations in response the wireless signals. The signal-receiving device includes a patch antenna including a dielectric substrate having a first surface and a second surface opposite to the first surface, a ground layer disposed on the first surface, and a radiating metal layer. The radiating metal layer is disposed on the second surface and includes a radiation receiving surface. A first position of the radiation receiving surface is separated from the ground layer by a first distance, and a second position of the radiation receiving surface is separated from the ground layer by a second distance less than the first distance.

Wireless transmission system

A topical formulation comprising (a) a therapeutically effective amount of tofacitinib; (b) at least one solvent; and (c) optionally one or more other pharmaceutically acceptable excipients is provided. Also provided is a method for treating and/or preventing autoimmune diseases in a subject administering said topical formulation.

Topical formulations comprising tofacitinib

A power supply unit where the main DC voltage output rail is incorporated within the enclosure of the power supply unit and some DC voltage output rails and DC-DC converters are located outside the enclosure of the power supply unit close to or directly at the input of the system board and input of associated system peripheral via integration into a cable harness assembly, to negate the voltage drop on the cable harness assembly, resulting in a lower power loss across the cable harness assembly, leading to an improvement in combined power supply unit and cable harness assembly efficiency.

Power supply unit with some DC-DC converters located outside the enclosure and integrated into cable harness assembly

A key preloading structure including a base, a set of switches and a set of keys is provided. The set of switches is arranged on the base. The set of keys has a rotating shaft and two actuators. The rotating shaft is assembled on the base. One end of each actuator is fixedly connected to the rotating shaft, and another end is disposed on a switch of the set of switches. Each of the two actuators preloads the set of switches with a force less than a triggering force for starting the set of switches.

Key preloading structure and assembly method thereof

A multi-body device includes a first machine body, a second machine body, a rotating member, a first magnetic member, a second magnetic member, and a stopper. The second machine body is pivoted to a pivot side of the first machine body. The rotating member is pivoted to the pivot side of the first machine body and located beside the second machine body. The first magnetic member is disposed at the second machine body. The second magnetic member is disposed at a portion of the rotating member corresponding to the first magnetic member. Two corresponding ends of the first magnetic member and the second magnetic member are magnetically repulsive to each other. The stopper is driven by the second machine body and disposed at the pivot side of the first machine body, so as to stretch into or retreat from a rotation path of the rotating member.

Multi-machine-body device

A lifting device is applied to an input assembly, and includes: a base, a supporting base, and a connecting rod mechanism, where the base bears the input assembly and includes a lower protruding portion; the supporting base is movably disposed corresponding to the base and includes a base portion and a notch, and the notch is disposed corresponding to the lower protruding portion; the connecting rod mechanism includes an output rod and an input rod, where the output rod is connected to the supporting base; the input rod is linked with the output rod, and drives the output rod to move, so that the supporting base moves relative to the base, and when movement of the supporting base makes the lower protruding portion move from the notch to the base portion, the base ascends by a height.

Lifting device for input assembly, and keyboard and electronic device thereof

The application discloses a support device, mounted in a portable electronic device, including an upper-cover shell, a base shell, and a pivot. The support device includes a cam structure, a first rod member, a second rod member, and a support member. The cam structure is connected to the pivot. The first pivot portion and the second pivot are pivotally connected to the base shell. The first rod member is in contact with the cam structure, and includes a first slide portion. The second rod member includes a second slide portion, movably connected to the first slide portion. The support member penetrates through an opening of the base shell, where a top surface of the support member and the second rod member are in contact with each other.

Portable electronic device and support device thereof

A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.

Oral controlled release dosage form

The disclosure discloses a computing device including a connection module, a processing unit and a logic expansion unit, and a power supply method of a connection module. The connection module includes a detection unit and a power switch. The detection unit is configured to detect whether the connection module is connected with an external peripheral device, and to generate a detection signal. The power switch is configured to receive a power switching signal and to provide a rated voltage to the connection module according to the power switching signal. The processing unit and the logic expansion unit are coupled to each other. When the computing device is at a normal mode, the processing unit is configured to provide the power switching signal, acquires a connection status between the connection module and the external peripheral device, and to control the logic expansion unit to record the connection status.

Computing device and power supply method of connection module

An electronic device and a method for starting up the same, wherein the electronic device includes a firmware control unit, a power supply state storage unit, a basic input output unit, and an Ethernet interface coupled to power supply apparatus to a Power over Ethernet to receive a power supply via a network cable. The firmware control unit determines whether the power supply state of the power supply is in a first power mode, by checking a power supply state signal. When the power supply state is not in the first power mode, the basic input output unit executes a second power booting program. The firmware control unit communicates with the power supply apparatus via a network, increases the rated power of the power supply, sets the power supply state signal for controlling the power supply state to be in the first power mode, and restarts the electronic device.

Electronic device and start-up method thereof

Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1&#x3b2; modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1&#x3b2; modulator.

Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia

Controlled release oral solid dosage form for the reduction of serum cholesterol levels in humans include a drug comprising an alkyl ester of hydroxy substituted naphthalenes (e.g., lovastatin) and a controlled release carrier, such that the dosage form provides a mean time to maximum plasma concentration (T) of the drug which occurs at about 10 to about 32 hours after oral administration on a once-a-day basis to human patients. The dosage form provides a therapeutically effective reduction in serum cholesterol levels. Methods of reducing serum cholesterol levels in humans are also disclosed.

HMG-CoA reductase inhibitor extended release formulation

The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic control of type II diabetes patients and/or reducing side effects and/or cardiovascular risks of antidiabetic agents.

Methods of using diacerein as an adjunctive therapy for diabetes

Sustained release pharmaceutical formulations comprising an antihyperglycemic drug or a pharmaceutically acceptable salt thereof are disclosed. The formulations provide therapeutic plasma levels of the antihyperglycemic drug to a human patient over a 24 hour period after administration.

Controlled release metformin formulations

Growing community of inventors

Taipei, Taiwan

Chih-Ming Chen